Trials / Completed
CompletedNCT05102058
Magnesium and Dexmedetomidine in Pheochromocytoma
Magnesium and Dexmedetomidine Combination Reduces Sodium Nitroprusside Requirement in Laparoscopic Pheochromocytoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (actual)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Anesthesia management of pheochromocytoma excision surgery is associated with severe hemodynamic fluctuations.The objective of this study was to compare the hypertensive episodes requiring sodium nitroprusside administration between the group treated with magnesium-dexmedetomidine and conventional group in pheochromocytoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium-Dexmedetomidine | Received oral 300 mg magnesium one week before surgery and magnesium-dexmedetomidine combination perioperatively |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2021-11-01
- Last updated
- 2021-11-01
Source: ClinicalTrials.gov record NCT05102058. Inclusion in this directory is not an endorsement.